Park Medi World FY26 Revenue Hits Record ₹16,794 Crore, Profit Up 27%
Park Medi World reported record FY'26 results with revenue at ₹1,679.4 crore (up 21% YoY) and net profit at ₹273.6 crore (up 27% YoY). Q4 FY'26 revenue rose 30% to ₹460.4 crore, and net profit increased 47% to ₹76.8 crore. The company added 610 beds via acquisitions and commissioned a new hospital, increasing total capacity to 3,960 beds.
The announcement details record financial results and significant capacity expansion, which are material events for the company and will likely impact investor perception and stock performance.
The company reported record financial performance for FY'26 and Q4 FY'26, showing significant year-on-year growth in revenue, EBITDA, and net profit, alongside strategic capacity expansion.
Park Medi World Limited announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The company reported its strongest year to date in FY'26, with record performance across key metrics and its largest annual capacity expansion in two decades.
For the full year FY'26, Park Medi World recorded its highest ever revenue of INR 16,794 million (₹1,679.4 crore), a growth of 21% year-on-year. EBITDA also reached a record high of INR 4,443 million (₹444.3 crore), up 20% YoY, with an EBITDA margin of 26.5%. Net profit surged by 27% YoY to INR 2,736 million (₹273.6 crore), resulting in a net profit margin of 16.3%, an expansion of 83 basis points YoY. Cash from operations stood at INR 3,291 million (₹329.1 crore). The company also reported a reduction in debtor days from 161 to 129 and maintained negligible term bank debt of INR 282 million (₹28.2 crore) with strong liquidity of INR 5,509 million (₹550.9 crore) in cash and cash equivalents.
Growth in FY'26 was driven by a 20% capacity addition, with 610 beds added through acquisitions in Bhatinda (250 beds) and Agra (360 beds), increasing the total bed capacity to 3,610 beds as of March 31, 2026. The company also completed its largest greenfield hospital in Panchkula (350 beds), which was commissioned on April 10, 2026, bringing the total bed capacity to 3,960 beds. Further expansion includes the acquisition of Febris Multi-Superspeciality Hospital (200 beds) in Narela, Delhi, expected to be commissioned in Q2 FY'27, and a 150-bed expansion at the Mohali facility, expected to be operational within 12-15 months.
For the fourth quarter of FY'26, revenue grew by 30% YoY to INR 4,604 million (₹460.4 crore). EBITDA increased by 44% YoY to INR 1,274 million (₹127.4 crore) with an improved EBITDA margin of 27.7%. Net profit saw a significant jump of 47% YoY to INR 768 million (₹76.8 crore), with a net profit margin of 16.7%.
What to do with a filing like this
Park Medi World Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Park Medi World Limited. Read the original for the full detail.